Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Guidance and Visibility -- Ignore unavailable to you. Want to Upgrade?

To: Findit who wrote (107123)	2/3/2004 10:02:43 AM
From: CRUZ	Respond to of 208838

Out HUGO @ 5.62 + .20

To: Findit who wrote (107123)	2/3/2004 10:04:43 AM
From: wlcnyc	Read Replies (1) \| Respond to of 208838

TRPH - making a nice "comeback" - hod 6.67 = + .38 CLN - moving up on good volume - hod 1.75 = +.08 Bill

To: Findit who wrote (107123)	2/3/2004 10:07:07 AM
From: CRUZ	Respond to of 208838

Jim, Picked up SCO yesterday@ 2.06 for longer term hold. Cruz

To: Findit who wrote (107123)	2/3/2004 10:08:10 AM
From: Mike C2	Read Replies (1) \| Respond to of 208838

CLN news biz.yahoo.com Based upon safety data submitted by Celsion for the first two groups of patients in the study, the FDA has allowed expansion of the study to include patients with progressive prostate cancer in-situ (i.e. non-metastatic). In addition, the FDA has permitted the Company to add an additional site, Grand Strand Urology in Myrtle Beach, South Carolina, to its existing clinical sites at Roswell Park Cancer Institute in Buffalo, New York and Regional Urology in Shreveport, Louisiana.